1naresh2naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [57966484-72b8-43e2-81b7-10b4b62d8b56] => Array ( [runtime-id] => 57966484-72b8-43e2-81b7-10b4b62d8b56 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [5f37bf7b-99b2-437b-b088-5cf30b1ab3a1] => Array ( [runtime-id] => 5f37bf7b-99b2-437b-b088-5cf30b1ab3a1 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;92934a8c80298c8576b284f10bb9fcc4ece180d5 ) ) ) 1naresh2nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => FreeToRead [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) [500eb3c2-8be9-45c4-bff7-988ed674b652] => Array ( [runtime-id] => 500eb3c2-8be9-45c4-bff7-988ed674b652 [type] => toll-free-key [service-id] => ajnr-ac.highwire.org [access-type] => FreeToRead [privilege] => Array ( [5c18dd07-d8ac-4a27-a666-5ceed25b1273] => Array ( [runtime-id] => 5c18dd07-d8ac-4a27-a666-5ceed25b1273 [type] => toll-free-key ) ) [credentials] => Array ( [method] => toll-free-key [value] => tf_ipsecsha;92934a8c80298c8576b284f10bb9fcc4ece180d5 ) ) ) PT - JOURNAL ARTICLE AU - Leinsinger, G AU - Piepgras, A AU - Einhäupl, K AU - Schmiedek, P AU - Kirsch, C M TI - Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT. DP - 1994 Aug 01 TA - American Journal of Neuroradiology PG - 1327--1332 VI - 15 IP - 7 4099 - http://www.ajnr.org/content/15/7/1327.short 4100 - http://www.ajnr.org/content/15/7/1327.full SO - Am. J. Neuroradiol.1994 Aug 01; 15 AB - PURPOSE To determine whether a standardized stimulation challenge with acetazolamide will be helpful for assessing the vasodilatory capacity in patients with obstructive cerebrovascular disease. METHODS To establish normative data of the cerebrovascular reserve capacity, a group of 41 control patients was investigated. The regional cerebral blood flow was measured quantitatively before and after stimulation with acetazolamide using the xenon 133 inhalation method and dynamic single-photon emission CT. RESULTS A significant increase of regional cerebral blood flow was found after administration of 1 g of acetazolamide. By doubling the dose no significant further increase was measured. We found no correlation of either baseline or stimulated flow values with age. However, a linear dependence between the stimulated flow values and their respective baseline values was observed. CONCLUSION The standardized challenge with acetazolamide seems to be a reliable method to determine cerebrovascular reserve capacity quantitatively.